Kowa Pharmaceuticals America (Diclofenac Products) Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • Asset Purch.
  • Financing Rounds
  • 2

Kowa Pharmaceuticals America (Diclofenac Products) General Information

Description

Portfolio of diclofenac products. The portfolio comprises of Cambia a diclofenac potassium for oral consumption used for the treatment of acute migraine headache pain.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Buildings and Property
Other Industries
Other Pharmaceuticals and Biotechnology
Pharmaceuticals
Drug Discovery
Primary Office
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Kowa Pharmaceuticals America (Diclofenac Products) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Kowa Pharmaceuticals America (Diclofenac Products)‘s full profile, request access.

Request a free trial

Kowa Pharmaceuticals America (Diclofenac Products) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Kowa Pharmaceuticals America (Diclofenac Products)‘s full profile, request access.

Request a free trial